April 23, 2025 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), developer of the innovative LIBERTY® Endovascular Robotic System, today announced the addition of two senior officers that ...

Microbot Medical Inc., a clinical-stage medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

With yields above 6%, these stocks offer at least four times the payout of the typical blue-chip stock.

Short interest in Microbot Medical Inc (NASDAQ:MBOT) increased during the last reporting period, rising from 5.52M to 6.41M. This put 17.73% of the company's publicly available shares short.

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Get the cash flow statement for Microbot Medical Inc. (MBOT). Up to 10 years of financial statements. Quarterly or annual. View as % YoY growth or as % of revenue. Skip to content ...

Get the detailed quarterly/annual income statement for Microbot Medical Inc. (MBOT). Find out the revenue, expenses and profit or loss over the last fiscal year.

Silver (XAG) Forecast: Price Drops Below $32.80 as Bulls Lose Key Technical SupportWed, 14 May 2025 12:48:36 GMT PLTR, SMCI and TSLA Forecast – Tech Stocks Look to Recover on WednesdayWed, 14 ...